- Home
- SLAB vs SLNO Comparison
SLAB vs SLNO Comparison
Compare SLAB & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLAB
- SLNO
- Stock Information
- Founded
- SLAB 1996
- SLNO 1999
- Country
- SLAB United States
- SLNO United States
- Employees
- SLAB N/A
- SLNO N/A
- Industry
- SLAB Semiconductors
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SLAB Technology
- SLNO Health Care
- Exchange
- SLAB Nasdaq
- SLNO Nasdaq
- Market Cap
- SLAB 3.5B
- SLNO 3.8B
- IPO Year
- SLAB 2000
- SLNO 2014
- Fundamental
- Price
- SLAB $141.30
- SLNO $79.98
- Analyst Decision
- SLAB Buy
- SLNO Strong Buy
- Analyst Count
- SLAB 9
- SLNO 9
- Target Price
- SLAB $125.22
- SLNO $103.33
- AVG Volume (30 Days)
- SLAB 348.8K
- SLNO 662.7K
- Earning Date
- SLAB 07-23-2025
- SLNO 08-06-2025
- Dividend Yield
- SLAB N/A
- SLNO N/A
- EPS Growth
- SLAB N/A
- SLNO N/A
- EPS
- SLAB N/A
- SLNO N/A
- Revenue
- SLAB $655,725,000.00
- SLNO N/A
- Revenue This Year
- SLAB $37.27
- SLNO N/A
- Revenue Next Year
- SLAB $19.90
- SLNO N/A
- P/E Ratio
- SLAB N/A
- SLNO N/A
- Revenue Growth
- SLAB 2.16
- SLNO N/A
- 52 Week Low
- SLAB $82.82
- SLNO $36.93
- 52 Week High
- SLAB $160.00
- SLNO $81.54
- Technical
- Relative Strength Index (RSI)
- SLAB 66.01
- SLNO 60.77
- Support Level
- SLAB $134.70
- SLNO $76.14
- Resistance Level
- SLAB $145.28
- SLNO $81.54
- Average True Range (ATR)
- SLAB 4.45
- SLNO 2.49
- MACD
- SLAB 0.67
- SLNO 0.00
- Stochastic Oscillator
- SLAB 84.47
- SLNO 81.81
About SLAB Silicon Laboratories Inc.
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.